Six reasons Democrats may miss a sweeping midterm victory
Reuters outlines six factors that could limit Democratic gains on November 3, from fewer competitive races to Republican advantages in money and turnout.
1 source · Reuters
central bank decisions, rates, inflation and data releases, explained through their market impact.
stories appear here with a 15-minute delay. in real time — via the api connect the api →
1699 stories · page 73 / 85
Reuters outlines six factors that could limit Democratic gains on November 3, from fewer competitive races to Republican advantages in money and turnout.
1 source · Reuters
The Russell 2000 neared correction territory before holding several support levels. Reuters says a rebound is possible, while a break below 2,722 could deepen losses.
1 source · Reuters
The New York Times says Elon Musk has given more than $276 million to Republican groups and his super PAC since July, ahead of midterms.
1 source · Seeking Alpha
Heineken repurchased 174,000 own shares and 174,920 from Heineken Holding. Total purchases in tranche two reached €604.7M by 9 Oct.
1 source · TradingView
Heineken Holding bought 174,920 shares for about €11.6M from 5–9 October 2026 under the second tranche of its buyback program.
1 source · TradingView
Crypto exchange Bullish has linked its BTC options records and market data to Elwood’s institutional platform, giving clients integrated post-trade oversight.
1 source · Crypto Briefing
BTIG maintained its Buy rating on Intuitive Surgical while cutting the stock’s price target to $454 from $469, Dow Jones Newswires reported.
1 source · Dow Jones Newswires
The rupee gained 1% after RBI measures curbed dollar demand and likely intervention supported the move, while analysts questioned how durable the recovery is.
2 sources · Moneycontrol, Reuters
Reuters reports that Virtual Mind Holding Chairman Mei Weiyi purchased 816,000 company shares on the market on October 9, 2026.
1 source · Reuters
First Tracks Biotherapeutics shares gained 15% after the company announced a Monday review of trial data for its celiac disease drug ANB033.
1 source · Dow Jones Newswires
Times China Holdings reported contracted sales of RMB279 million in September and RMB2,516 million for the first nine months of 2026.
1 source · Reuters
Monega, Societe Generale, Parvus, Harwood, UBS and Aberforth disclosed changes in voting rights and holdings across UK-listed companies.
10 sources · London Stock Exchange, Newsmetry API
Bernstein says AI agents could pressure Experian’s subscriptions and BillFixer product, while its North America consumer business nears ex-growth.
1 source · Dow Jones Newswires
BTIG raised its price target for Shoulder Innovations to $27 from $26 per share, Dow Jones Newswires reported, citing Benzinga’s ratings update.
1 source · Dow Jones Newswires
Reuters reports that an Infomina unit signed an 855 million yen mainframe software contract with Panasonic Digital, highlighting a new corporate agreement.
1 source · Reuters
China Hongguang Holdings’ board proposed lifting the company’s authorised share capital to HK$20 million, Reuters reported in its latest update.
1 source · Reuters
Pou Sheng International said its September net consolidated operating revenue reached RMB1.31 billion, according to the company’s disclosure.
1 source · Reuters
Reuters reports that United Malacca Bhd received a notice concerning a cash compensation scheme on October 12, 2026.
1 source · Reuters
Seeking Alpha highlights five market themes: Trump’s weak ratings, AI financing limits, Musk’s chip ambitions, the IMF outlook and Amazon’s Decart talks.
1 source · Seeking Alpha
BTIG began covering Quoin Pharmaceuticals with a Buy rating and a $14 target, implying 211.1% upside from the stock’s October 9 close at $4.50.
1 source · TradingView